Increasing competition within Europe’s pharmaceutical space makes knowing the market and understanding available patent protections more critical than ever for both well established and new market players. Andreas von Falck...more
5/18/2018
/ Biotechnology ,
Compulsory Licenses ,
Doctrine of Equivalents ,
EU ,
Generic Drugs ,
Injunctions ,
Intellectual Property Protection ,
Inventions ,
Litigation Strategies ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Popular ,
Prescription Drugs ,
Technology Sector